Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers

Overview of attention for article published in Frontiers in immunology, February 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 50,094 followers.

Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers https://t.co/Mm5fVn9KD5 https://t.co/booM0QvoM5

16 Feb 2023

Reply Repost Favourite

New Research: Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers: Background Tislelizumab is an anti-programmed cell death 1 (PD-1) monoclonal antibody engineered to minimize binding to Fcγ… https://t.co/k

16 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.